Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study)

Ophthalmology

Volumn 110, Issue 2, 2003, Pages 400-405

  Holz, Frank G ^a   Jorzik, Jork ^a   Schutt, Florian ^a   Flach, Ulrike ^a   Unnebrink, Kristina ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CORRELATION COEFFICIENT; DISEASE CLASSIFICATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RELIABILITY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

EID: 0037314680     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01770-0     Document Type: Article

References (33)

1. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933-43.
2. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980; 24(Suppl):335-610.
3. Wormald R. Assessing the prevalence of eye disease in the community. Eye 1995;9:674-6.
4. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1986;104:694-701.
5. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1991;109:1220-31.
6. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1994;112:500-9.
7. Freund KB, Yannuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993;115:786-91.
8. Soubrane G, Coscas G, Français C, Koenig F. Occult subretinal new vessels in age-related macular degeneration. Natural history and early laser treatment. Ophthalmology 1990;97:649-57.
9. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year-results of 2 randomized clinical trials - TAP report 1. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group [published erratum appears in Arch Ophthalmol 2000; 118:488]. Arch Ophthalmol 1999; 117:1329-45.
10. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD-Study). The Radiation Therapy for Age-related Macular Degeneration StudyGroup. Ophthalmology 1999;106:2239-2247.
11. Rezai KA, Kohen L, Wiedemann P, Heimann K. Iris pigment epithelium transplantation. Graefes Arch Clin Exp Ophthalmol 1997;235:558-62.
12. Thomas MA, Grand MG, Williams DF, et al. Surgical management of subfoveal choroidal neovascularization. Ophthalmology 1992;99:952-68; discussion 975-6.
13. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol 1993;231:635-41.
14. De Juan E Jr, Loewenstein A, Bressler NM, Alexander J. Translocation of the retina for management of subfoveal neovascularization. II: a preliminary report in humans. Am J Ophthalmol 1998;125:635-46.
15. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with agerelated macular degeneration. Graefes Arch Clin Exp Ophthalmol 1999;237:313-25.
16. Challa JK, Gillies MC, Penfold PL, et al. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol 1998;26:277-81.
17. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994;91:4082-5.
18. Interferon alfa-2 is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group. Arch Ophthalmol 1997;115:865-72.
19. Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: a review of experimental treatments. Surv Ophthalmol 1998;43:134-46.
20. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Verteporfin in Photodynamic Therapy Study Group. Am J Ophthalmol 2001;131:541-60.
21. Reichel E, Berrocal AM, Ip M, et al. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology 1999;106:1908-14.
22. Staurenghi G, Orzales N, La Capria A, Aschero M. Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography. Ophthalmology 1998;105:2297-305.
23. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group. Arch Ophthlamol 1991;109:1242-57.
24. Holz FG, Bellmann C, Rohrschneider K, et al. Simultaneous confocal scanning laser fluorescein- and indocyanine green angiography. Am J Ophthlamol 1998;125:227-36.
25. Altman DG. Practical Statistics for Medical Research. Boca Raton, FL: Chapman & Hall/CRC, 1991;403-9.
26. Krummenauer F. Erweiterungen von Cohen's Kappa-Mass β für Multi-Rater-Studien. Eine Übersicht. Informatik, Biom Epidemiol Med Biol 1999;30:3-20.
27. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
28. Friedman SM, Margo CE. Choroidal neovascular membranes: reproducibility of angiographic interpretation. Am J Ophthalmol 2000;130:839-41.
29. Abrams LS, Scott IU, Spaeth GL, et al. Agreement among optometrists, ophthalmologists, and residents in evaluating the optic disc for glaucoma. Ophthalmology 1994;101:1662-7.
30. Miñana S, Riquelme Miralles DA. Variability in the interpretation of thorax radiography in a primary care medical community and first reference radiologist. Aten Primaria 1998;31:599-606.
31. Fletcher BD, Glicksman AS, Gieser P. Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography. J Clin Oncol 1999;17:2153-9.
32. 99Tcm-sestamibi myocardial perfusion SPECT in a consecutive group of male patients with stable angina pectoris before and after percutaneous transluminal angioplasty. Nucl Med Commun 2001;22:531-7.
33. King AJ, Farnworth D, Thompson JR. Inter-observer and intra-observer agreement in the interpretation of visual fields in glaucoma. Eye 1997;11:687-91.